Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | ACP1 | P24666 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28915783 | 0.97 | TGFBR1 (0.38) | TGFBR1ALDH1A1TDP1FNTAFNTB | |
| SCHEMBL11546233 | 0.97 | TGFBR1 (0.38) | TGFBR1ALDH1A1TDP1FNTAFNTB | |
| Ammonia Solution, Strong SCHEMBL29930752 | 0.97 | TGFBR1 (0.38) | TGFBR1ALDH1A1TDP1FNTAFNTB | |
| Methacrylic Acid SCHEMBL9986600 | 0.93 | TGFBR1 (0.39) | TGFBR1ALDH1A1TDP1FNTAFNTB | |
| SCHEMBL194405 | 0.79 | TGFBR1 (0.39) | TGFBR1ALDH1A1TDP1KDM4ERXFP1 | |
| SCHEMBL4422753 | 0.77 | TDP1 (0.39) | TGFBR1ALDH1A1TDP1FNTAFNTB | |
| Potassium Ion SCHEMBL11546232 | 0.75 | TGFBR1 (0.36) | TGFBR1ALDH1A1TDP1KDM4E | |
| SCHEMBL195115 | 0.75 | TGFBR1 (0.41) | TGFBR1ALDH1A1TDP1KDM4E | |
| SCHEMBL19291563 | 0.75 | — | — | |
| SCHEMBL6013944 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3825385-B1 | DIAGNOSTIC DETERMINATION OF CLEANING PERFORMANCE BY USING FLUORESCENT POLYMERS IN MARKING COMPOSITIONS | ECOLAB USA INC (US) | 2024-06-12 | — | — | EP | claimed |
| US-20240006717-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO LTD (KR) | 2024-01-04 | — | — | US | claimed |
| EP-3762119-B1 | CHROMATOGRAPHIC SEPARATION OF AMMONIUM SULPHATE AND OF 2-HYDROXY-2-METHYLPROPIONIC ACID | TRINSEO EUROPE GMBH (CH) | 2023-12-06 | — | — | EP | claimed |
| WO-2023200107-A1 | SEPARATOR FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME | 삼성에스디아이 주식회사 | 2023-10-19 | — | — | WO | claimed |
| WO-2023200106-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | 삼성에스디아이 주식회사 | 2023-10-19 | — | — | WO | claimed |
| WO-2023200104-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | 삼성에스디아이 주식회사 | 2023-10-19 | — | — | WO | claimed |
| WO-2023200105-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | 삼성에스디아이 주식회사 | 2023-10-19 | — | — | WO | claimed |
| WO-2023200109-A1 | SEPARATOR FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME | 삼성에스디아이 주식회사 | 2023-10-19 | — | — | WO | claimed |
| US-11764441-B2 | Separator for rechargeable lithium battery and rechargeable lithium battery including the same | SAMSUNG SDI CO., LTD. (KR) | 2023-09-19 | — | — | US | claimed |
| US-11426496-B2 | Method for preparing anti-bacterial surface on medical material surface | SOUTH CHINA UNIVERSITY OF TECHNOLOGY | 2022-08-30 | — | — | US | claimed |
| US-20110318515-A1 | BIOMASS-DERIVED METHYL METHACRYLATE AND CORRESPONDING MANUFACTURING METHOD, USES AND POLYMERS | ARKEMA FRANCE (FR) | 2011-12-29 | — | — | US | claimed |
| US-20080221253-A1 | adding a organoamine salt of 2-acylamido-2-methylpropanesulfonic acid to a ethylenically unsaturated water insoluble monomer(s) mixture, water and a polymerization initiator such as benzoyl peroxide, polymerizing the monomer in latex formation | THE LUBRIZOL CORPORATION (US) | 2008-09-11 | — | — | US | claimed |
| EP-1718685-A1 | IMPROVIONG THE LIPOPHILIC PROPERTIES OF 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID | The Lubrizol Corporation (US) | 2006-11-08 | — | — | EP | claimed |
| EP-1275636-B1 | Process for preparing methacrylamide sulfate | ARKEMA (FR) | 2005-11-02 | — | — | EP | claimed |
| WO-2005080451-A1 | IMPROVIONG THE LIPOPHILIC PROPERTIES OF 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID | THE LUBRIZOL CORPORATION (US) | 2005-09-01 | — | — | WO | claimed |
| US-6750368-B2 | FROM ACETONE CYANOHYDRIN, SULPHURIC ACID AND SULFUR TRIOXIDE IN A MULTISTEP PROCESS | ATOFINA (FR) | 2004-06-15 | — | — | US | claimed |
| US-20030088123-A1 | Process for preparing sulphuric methacrylamide and device for implementing it | TRINSEO EUROPE GMBH (CH) | 2003-05-08 | — | — | US | claimed |
| EP-0561264-B1 | Improved process for the production of methylmethacrylate monomer from acetoncyanhydrin | ATOCHEM ELF ITALIA (IT) | 1996-08-14 | — | — | EP | claimed |
| EP-0459661-B1 | Silica scale inhibition | ROHM & HAAS (US) | 1995-08-02 | — | — | EP | claimed |
| EP-0461823-B1 | Purification process of methacrylamide | MITSUI TOATSU CHEMICALS (JP) | 1994-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110318515-A1 | BIOMASS-DERIVED METHYL METHACRYLATE AND CORRESPONDING MANUFACTURING METHOD, USES AND POLYMERS | ACMSD, MMAB, MCM6 | TGFBR1 1783/4885ALDH1A1 541/4885TDP1 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.